ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EDEN Eden Research Plc

4.85
0.225 (4.86%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.225 4.86% 4.85 4.70 5.00 4.85 4.625 4.63 296,354 16:20:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -11.55 25.87M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.63p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £25.87 million. Eden Research has a price to earnings ratio (PE ratio) of -11.55.

Eden Research Share Discussion Threads

Showing 12251 to 12263 of 18050 messages
Chat Pages: Latest  494  493  492  491  490  489  488  487  486  485  484  483  Older
DateSubjectAuthorDiscuss
12/5/2022
06:33
Employees or contractors agents of Cenkos and Hawthorn Financial PR should not be posting on this board without declaring their interest. I am retired and have no financial interest in Eden and it's litany of failure.
ravenna23
12/5/2022
06:29
Sorry this should have read the Financial Reporting Council FRC, not the FCA.
ravenna23
11/5/2022
21:07
Sense Receptor@SenseReceptor

Here is an overview of how every single one of Moderna’s mRNA products either failed or did not come to market prior to “Warp Speed.” This list includes source evidence and studies evincing the dangerous nature of mRNA/lipid nanoparticle technology.

supersonico
11/5/2022
14:53
Forger above, why keep doing for free what ar$eholes would pay you to do? Check ravenna's post from earlier today for contact details.
neutralpov
11/5/2022
14:37
Just above, the lying forger keeps on trolling.

Doesn't hold a single share in this diseased pooch, the archetypal Sucker Stock for coprophiliacs....

But consciencelessly encourages suckers to buy it.

Approach Investisatrickygame's immediate employer, forger, and offer to do what the pay that liar to do for half the price.

=====

And the SP's slump is today resumed.

neutralpov
11/5/2022
13:41
ravenna23 11 May '22 - 13:21 - 11820
> Doomsday for Eden, June 30th, the last day they can publish 2021 accounts. Tick tock.


Spot on, ravenna!

And we know from the FCA's ruling the level to which they may stoop if they think they'll get away with it.

The less-idiotic larger PIs will jump ship before the accounts are published.

=====

Below, the lying forger keeps on spamming.

neutralpov
11/5/2022
13:33
By 2024 Eden will be bust.
ravenna23
11/5/2022
13:21
Doomsday for Eden, June 30th, the last day they can publish 2021 accounts. Tick tock.
ravenna23
11/5/2022
13:18
Tricky! Have you lost the plot, why are you posting stuff from 2021. Try reposting the FCA ruling, or the last set of accounts if you want to give potential investors a true picture of Edens prospects. Do you work for Hawthorn Financial PR? Big volume today, everyone must be reading your posts.
ravenna23
11/5/2022
12:25
10/12/2021 Eden's US EPA is scheduled



10/05/2021 "Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and a plastic-free formulation technology for use in global crop protection, animal health and consumer products industries, announces that it has passed a key milestone in the US for the approval of its products, Mevalone® and Cedroz."

hxxps://polaris.brighterir.com/public/eden_research/news/rns/story/w6d5q9x

investingisatrickygame
11/5/2022
12:02
Keep in mind the Bayer / Corteva / Eden 'consolidator' 2024 timeline.

EU agencies push back glyphosate assessment to mid-2023

supersonico
11/5/2022
11:17
Through means miraculous, I can warn any decent ones (like Brucie5, except he's much smarter and stopped being a holder years ago) that TW is preparing a slamming expose on this stock. Sell when you can would appear to be sensible. You can then buy back and get twice or thrice the number.
neutralpov
11/5/2022
08:43
Barge poles have their place but are a blunt tool in complex systems...unable to determine on their own the light at the end of the tunnel or it's intensity.
supersonico
Chat Pages: Latest  494  493  492  491  490  489  488  487  486  485  484  483  Older